CINDY KIRKLAND: Open Payments
NPI 1518103670 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,472 in 95 payments from 18 companies in 2025. Trend: 2023 $528 · 2024 $274 · 2025 $2,472
Food & beverage: $2,472
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $656 |
| ABBVIE INC. | 21 | $451 |
| Ardelyx, Inc. | 6 | $219 |
| QOL Medical, LLC | 6 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $185 |
| GENZYME CORPORATION | 4 | $143 |
| INTUITIVE SURGICAL, INC. | 1 | $133 |
| PFIZER INC. | 7 | $114 |
| Madrigal Pharmaceuticals | 3 | $110 |
| Aimmune Therapeutics, Inc. | 3 | $55 |
Products named: TREMFYA, IBSRELA, Sucraid, DUPIXENT, RINVOQ, ENTYVIO, Da Vinci Surgical System, VELSIPITY.
Industry payments across FL — which companies pay providers there.
